Chairs
Current Chair: Neha Patel
Chair-elect candidate: Dania Alhamad
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics
March 30, 2026
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics…
New Meds and Tech: DESMODA™ (desmopressin acetate) Oral Solution
March 24, 2026
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution …
New Meds and Tech: Mounjaro (tirzepatide) approved in Pediatrics
February 24, 2026
Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs…